A recent survey commissioned by Allianz found that 67% of US respondents worry more about outliving their money than about death itself. For the Munich-based insurer, that statistic reads as a growth catalyst. The same study showed 39% fear unmanageable healthcare costs and 38% expect cuts to state pensions, a combination that plays directly into Allianz’s core lines of retirement products and life insurance. Yet the behavioral gap is wide: 65-year-old couples withdraw only 2.1% of their savings annually, well below the recommended 4% rule, leaving a vast pool of unmet demand the company is well positioned to tap.
The investment case, however, is not without countercurrents. Allianz stock closed Friday at €422.80, a mere 0.63% below its 52-week high of €425.50 set on July 10. The shares have climbed 9.28% over the past 30 days and are up 8.77% year-to-date, while the 12-month gain stands at 22.09%. The distance to the 200-day moving average of €376.34 has stretched to 12.35%, underscoring the strength of the rally. With a market capitalization of roughly €160 billion, the company remains one of the most heavily weighted names in the DAX.
Technically, the advance looks stretched. The 14-day relative strength index sits at 75.5, well above the 70 threshold that typically signals overbought conditions. That reading suggests a consolidation or pullback may be imminent. Still, the 30-day volatility of just 11.05% indicates the stock has been remarkably stable during its recent run. Some analysts point to widening credit spreads on highly valued technology stocks as a warning for momentum-driven markets, but Allianz’s status as a classic financial value name has helped it absorb that pressure.
Should investors sell immediately? Or is it worth buying Allianz?
The most direct threat to the insurer’s near-term earnings comes from the domestic economy. Germany recorded 2,276 corporate insolvencies in April alone, a 7.1% increase year-on-year that pushed first-half figures to a 20-year high. The Leibniz Institute for Economic Research reported 4,996 cases in the second quarter, with transport, logistics and construction hit hardest. Outstanding claims from January through April already total an estimated €13.9 billion. As a major provider of trade credit insurance and industrial liability coverage, Allianz faces rising loss ratios in its property-casualty segment. The next quarterly results will show whether the portfolio’s diversification can absorb the spike in defaults.
A second headwind emerged over the weekend. On July 12 the federal government approved a healthcare reform slated to take effect on January 1, 2027. While the general contribution rate stays at 14.6%, the supplementary premiums become more flexible, allowing low-cost public providers — such as bkk firmus with its 2.18% supplementary rate — to undercut established players. Though the reform applies directly only to statutory insurance, industry experts watch its spillover into private health coverage, a key profit center for Allianz. Counterbalancing the reform, President Steinmeier welcomed a separate coalition package of tax relief beginning in 2027, aimed at reviving economic growth.
The stock now sits at the intersection of two powerful but opposing forces: the structural tailwind from an aging population’s retirement anxiety, which supports Allianz’s long-term asset management and life insurance business, and the cyclical headwind from rising credit defaults and regulatory pressure on its health arm. The immediate market focus is on whether the share price can break decisively above €425.50. A sustainable move through that level would signal the start of a new leg higher, but with the RSI already flashing overbought, traders are likely to wait for either a dip to buy or a catalyst from the next earnings report to confirm the trend.
Ad
Allianz Stock: Buy or Sell?! New Allianz Analysis from July 13 delivers the answer:
The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 13.
Allianz: Buy or sell? Read more here...
